![]() |
Volumn 44, Issue 5, 1999, Pages 679-688
|
The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
CEFIXIME;
CIPROFLOXACIN;
GEMIFLOXACIN;
LEVOFLOXACIN;
NALIDIXIC ACID;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TROVAFLOXACIN;
UNCLASSIFIED DRUG;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BACTEROIDES FRAGILIS;
COMPARATIVE STUDY;
CONTROLLED STUDY;
ENTEROBACTERIACEAE;
HAEMOPHILUS INFLUENZAE;
IN VITRO STUDY;
LABORATORY TEST;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
MORAXELLA CATARRHALIS;
PSEUDOMONAS AERUGINOSA;
RESPIRATORY TRACT INFECTION;
SERRATIA;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PNEUMONIAE;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
BACTERIA;
BACTERIAL INFECTIONS;
EVALUATION STUDIES;
FLUOROQUINOLONES;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
NAPHTHYRIDINES;
|
EID: 0032739708
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/44.5.679 Document Type: Article |
Times cited : (51)
|
References (6)
|